TCM globalization
TCM globalization
-
Public Private Partnerships Accelerate TCM Innovation
How PPPs bridge lab-to-market gaps in Traditional Chinese Medicine—AI diagnostics, global clinical trials, WHO alignment, and cross-border scaling. Updated: August 2026.
2026-08-08
-
Evidence Based TCM Meets Global Clinical Trial Standards
How evidence-based TCM is aligning with FDA/EMA trial frameworks for herbal drugs — from AI-assisted diagnosis to WHO-endorsed standardization and cross-border regulatory pathways.
2026-08-04
-
TCM Wellness Programs Enter Corporate Health Benefits
How evidence-based TCM wellness programs are integrating into North American corporate health benefits—covering AI-assisted diagnostics, WHO-aligned standards, clinical trial benchmarks, and cross-...
2026-06-30
-
Real World Evidence From TCM Hospitals Supports WHO Tradi...
How real-world data from Chinese TCM hospitals advances WHO's Traditional Medicine Strategy — with AI-assisted diagnostics, standardized trials, and cross-border integration.
2026-06-29
-
Medical Tourism With TCM Services Grows Across Thailand M...
How Thailand, Malaysia, and Dubai are scaling medical tourism with TCM services — from AI-assisted diagnosis to WHO-aligned standards and cross-border clinical integration.
2026-06-28
-
China US Collaboration Advances Acupuncture Integration I...
How China-US partnerships are driving evidence-based acupuncture integration in U.S. healthcare—covering AI-assisted diagnosis, FDA-aligned clinical trials, WHO strategy alignment, and cross-border...
2026-06-27